Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA-Reference-Cited by-同舟云学术

Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA

Published:2021-09-01 Issue:9 Volume:7 Page:1378
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Schweizer Michael T.¹²,Sivakumar Smruthy³,Tukachinsky Hanna³,Coleman Ilsa⁴,De Sarkar Navonil⁴,Yu Evan Y.¹²,Konnick Eric Q.⁵,Nelson Peter S.¹⁴,Pritchard Colin C.⁵⁶,Montgomery Bruce¹⁷

Affiliation:

1. Division of Oncology, Department of Medicine, University of Washington, Seattle

2. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

3. Foundation Medicine, Cambridge, Massachusetts

4. Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington

5. Department of Laboratory Medicine and Pathology, University of Washington, Seattle

6. Brotman Baty Institute for Precision Medicine, Seattle, Washington

7. Prostate Cancer Foundation Precision Oncology Program for Cancer of the Prostate,VA Puget Sound Health Care System, Seattle, Washington

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2780857/jamaoncology_schweizer_2021_br_210011_1631288624.30224.pdf

Reference15 articles.

1. Integrative clinical genomics of advanced prostate cancer.;Robinson;Cell,2015

2. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.;Le;Science,2017

3. Mismatch repair deficiency in metastatic prostate cancer: response to PD-1 blockade and standard therapies.;Graham;PLoS One,2020

4. Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1 or BRCA2 gene alteration.;Abida;J Clin Oncol,2020

5. Olaparib for metastatic castration-resistant prostate cancer.;de Bono;N Engl J Med,2020

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing;ESMO Open;2024-09

2. PROTACing the androgen receptor and other emerging therapeutics in prostate cancer;Expert Review of Anticancer Therapy;2024-07-22

3. Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis;Modern Pathology;2024-06

4. Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution;Clinical and Translational Oncology;2024-05-09

5. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes;Annals of Oncology;2024-05